(ČIA) Three plasmacentres and three state hospitals in the Czech Republic participated in the international research of a new medicinal product for COVID-19. Therefore, private plasma centres have started collecting blood plasma from patients treated with coronavirus. The Association for Plasmapheresis (SPPF) reported that doctors from Chinese hospitals administered antibody-rich plasma to seriously ill patients, who subsequently improved significantly within a few days.